.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Mallinckrodt
QuintilesIMS
Cantor Fitzgerald
AstraZeneca
Dow
McKesson
Colorcon
Chubb

Generated: September 26, 2017

DrugPatentWatch Database Preview

Ranitidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ranitidine hydrochloride and what is the scope of ranitidine hydrochloride patent protection?

Ranitidine hydrochloride
is the generic ingredient in seven branded drugs marketed by Ranbaxy, Wockhardt, Apotex Inc, Bio Pharm Inc, Glaxo Grp Ltd, Pharm Assoc, Dr Reddys Labs Inc, Amneal Pharms, Strides Pharma, Watson Labs, Sandoz, Sanofi Us, Aurobindo Pharma Ltd, Mylan, Actavis Mid Atlantic, Amneal Pharms Ny, Watson Labs Inc, Perrigo R And D, Sun Pharm Inds Ltd, Zydus Pharms Usa Inc, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Tolmar, Teva, West-ward Pharms Int, Boehringer Ingelheim, Bedford, Ivax Sub Teva Pharms, Mylan Labs Ltd, Taro, Hi Tech Pharma, Apotex, Par Pharm, Breckenridge Pharm, Silarx, Teligent, Vintage Pharms, Nostrum Labs Inc, Contract Pharmacal, Glaxosmithkline, and Perrigo, and is included in seventy NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-three drug master file entries for ranitidine hydrochloride. One hundred and forty-one suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: ranitidine hydrochloride

Tradenames:7
Patents:0
Applicants:41
NDAs:70
Drug Master File Entries: see list43
Suppliers / Packagers: see list141
Bulk Api Vendors: see list83
Clinical Trials: see list2,360
Patent Applications: see list3
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ranitidine hydrochloride at DailyMed

Pharmacology for Ingredient: ranitidine hydrochloride

Tentative approvals for RANITIDINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 150MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 300MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 25MG BASE/MLINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bio Pharm Inc
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
SYRUP;ORAL090102-001May 26, 2009AARXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
SYRUP;ORAL078890-001Jul 1, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
Sanofi Us
ZANTAC 75
ranitidine hydrochloride
TABLET, EFFERVESCENT;ORAL020745-001Feb 26, 1998DISCNYesNo► Subscribe► Subscribe► Subscribe
Apotex
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
TABLET;ORAL074680-001Sep 12, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
INJECTABLE;INJECTION079076-001Jun 9, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
SYRUP;ORAL091091-001Sep 20, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
Glaxo Grp Ltd
ZANTAC 150
ranitidine hydrochloride
TABLET, EFFERVESCENT;ORAL020251-001Mar 31, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
TABLET;ORAL075294-001Mar 28, 2000OTCNoNo► Subscribe► Subscribe► Subscribe
Sandoz
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
CAPSULE;ORAL074655-001Oct 22, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride
TABLET;ORAL074552-002Jul 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ranitidine hydrochloride

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Dow
Chinese Patent Office
US Department of Justice
Healthtrust
Covington
US Army
Teva
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot